Korsana Biosciences (KRSA) Total Assets by Year
Korsana Biosciences, Inc. closed fiscal year 2025 with $154.6M in total assets, $188.6M in total liabilities and -$34.0M in shareholder equity. Total assets rose 1514.6% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Korsana Biosciences, Inc. has filed alongside them.
Ticker history: CYCN became KRSA (Korsana Biosciences, Inc.) on . Earlier news and filings retain their original names and dates. View CYCN history.
Annual figures, oldest first. Point at a bar to read its period.
KRSA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25Filing | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $154.6M+1514.6% | $9.6M-28.4% | $13.4M-26.0% | $18.1M-69.5% | $59.3M-48.6% | $115.4M-38.1% | $186.5M+2419.6% | $7.4M |
| Total Liabilities | $188.6M+1883.0% | $9.5M+355.8% | $2.1M-72.6% | $7.6M-31.2% | $11.1M-80.2% | $55.9M-37.0% | $88.7M+397.3% | $17.8M |
| Total Equity | -$34.0M-51566.7% | $66K-99.4% | $11.3M+8.0% | $10.5M-78.3% | $48.2M-18.9% | $59.5M-39.1% | $97.7Mn/m | -$10.4M |
KRSA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26Filing | Q4'25Filing | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $462.1M+4336.7% | $6.9M-26.0% | $8.5M-13.6% | $154.6M+1514.6% | $10.4M+17.0% | $9.4M-6.9% | $9.8M-13.3% | $9.6M-28.4% | $8.9M-41.5% | $10.1M-0.3% | $11.4M-0.8% | $13.4M-26.0% |
| Total Liabilities | $45.6M+41.3% | $70.2M+639.6% | $55.5M+464.9% | $188.6M+1883.0% | $32.3M+4507.3% | $9.5M+640.5% | $9.8M+582.2% | $9.5M+355.8% | $700K-70.1% | $1.3M-74.1% | $1.4M-80.9% | $2.1M-72.6% |
| Total Equity | $391.6Mn/m | -$63.3Mn/m | -$47.0M-294012.5% | -$34.0M-51566.7% | -$21.8M-366.4% | -$123K-101.4% | $16K-99.8% | $66K-99.4% | $8.2M-36.3% | $8.8M+70.5% | $9.9M+152.8% | $11.3M+8.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Korsana Biosciences, Inc. financials
Frequently Asked Questions
Korsana Biosciences, Inc. closed fiscal year 2025 with $154.6M in total assets, $188.6M in total liabilities and -$34.0M in shareholder equity.
Korsana Biosciences, Inc. (KRSA) total assets rose by 1514.6% year over year, from $9.6M to $154.6M in fiscal year 2025.
Across the 8 fiscal years this page covers, Korsana Biosciences, Inc. (KRSA) total assets went from $7.4M in fiscal year 2018 to $154.6M in fiscal year 2025.
Korsana Biosciences, Inc. (KRSA) reported $462.1M in total assets in Q3 2026. This represents an increase of 4336.7% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Korsana Biosciences, Inc. (KRSA) reported on that line in every period on record.